Due to the rapidly increasing sales volume of autoinjectors and injection pens (e.g. for insulin), pharmaceutical manufacturers are dependent upon testing systems that are efficient as well reliable. In addition to higher specimen throughput, increases in the areas of safety and the integration of new testing processes are a key issue for manufacturers. ZwickRoell has developed a special testing system that meets the current requirements of the pharmaceutical industry and is also designed to meet future requirements as well.
When using autoinjectors/pens, therapeutic success is greatly dependent upon the correct use of the injector. Therefore, pharmaceutical manufacturers strive to achieve a high level of automation in autoinjector technology. The patient simply removes the safety cap, positions the injector, and injects the drug by pressing a button—a process that is completely automated. However, this also means that all of the injector's relevant functions must be checked before the individual production batches are released on the market. This includes, for example, the removal force of the safety cap, activation force and displacement of the autoinjector and the effective needle length during injection.